Evidence map›Paper›PMID 38247998›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Interpretable Detection of Diabetic Retinopathy, Retinal Vein Occlusion, Age-Related Macular Degeneration, and Other Fundus Conditions.

Wenlong Li, Linbo Bian, Baikai Ma, Tong Sun, Yiyun Liu, Zhengze Sun, Lin Zhao, Kang Feng, Fan Yang, Xiaona Wang and 3 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wenlong LiDepartment of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.ORCID 0000-0002-2885-5065
Linbo BianDepartment of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.
Baikai MaDepartment of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.
Tong SunDepartment of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.
Yiyun LiuDepartment of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.
Zhengze SunDepartment of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.
Lin ZhaoDepartment of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.
Kang FengDepartment of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.
Fan YangDepartment of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.
Xiaona WangDepartment of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.ORCID 0000-0002-0950-6855
Szyyann ChanDepartment of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.
Hongliang DouDepartment of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.
Hong QiDepartment of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.

Funding

China Postdoctoral Science Foundation 2023M730122National Natural Science Foundation of China 82171022, 81974128,82371026, 82301177Peking University Medicine Sailing Program for Young Scholars' Scientific & Technological Innovation BMU2023YFJHPY016
6 · The paper itself

Abstract

Diabetic retinopathy (DR), retinal vein occlusion (RVO), and age-related macular degeneration (AMD) pose significant global health challenges, often resulting in vision impairment and blindness. Automatic detection of these conditions is crucial, particularly in underserved rural areas with limited access to ophthalmic services. Despite remarkable advancements in artificial intelligence, especially convolutional neural networks (CNNs), their complexity can make interpretation difficult. In this study, we curated a dataset consisting of 15,089 color fundus photographs (CFPs) obtained from 8110 patients who underwent fundus fluorescein angiography (FFA) examination. The primary objective was to construct integrated models that merge CNNs with an attention mechanism. These models were designed for a hierarchical multilabel classification task, focusing on the detection of DR, RVO, AMD, and other fundus conditions. Furthermore, our approach extended to the detailed classification of DR, RVO, and AMD according to their respective subclasses. We employed a methodology that entails the translation of diagnostic information obtained from FFA results into CFPs. Our investigation focused on evaluating the models' ability to achieve precise diagnoses solely based on CFPs. Remarkably, our models showcased improvements across diverse fundus conditions, with the ConvNeXt-base + attention model standing out for its exceptional performance. The ConvNeXt-base + attention model achieved remarkable metrics, including an area under the receiver operating characteristic curve (AUC) of 0.943, a referable F1 score of 0.870, and a Cohen's kappa of 0.778 for DR detection. For RVO, it attained an AUC of 0.960, a referable F1 score of 0.854, and a Cohen's kappa of 0.819. Furthermore, in AMD detection, the model achieved an AUC of 0.959, an F1 score of 0.727, and a Cohen's kappa of 0.686. Impressively, the model demonstrated proficiency in subclassifying RVO and AMD, showcasing commendable sensitivity and specificity. Moreover, our models enhanced interpretability by visualizing attention weights on fundus images, aiding in the identification of disease findings. These outcomes underscore the substantial impact of our models in advancing the detection of DR, RVO, and AMD, offering the potential for improved patient outcomes and positively influencing the healthcare landscape.

Indexed as

age-related macular degenerationautomated detectiondiabetic retinopathyinterpretableretinal vein occlusion

Identifiers

PMID38247998
PMCPMC11487407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.